Mamoon Rehman et al., 2016
No matter what, our recommendations will be unique to you
Of the 20 papers included for the GLP-1 subsample, three studies included data from healthy participants, 10 included individuals with overweight and obesity, seven included individuals with T2D, four studies investigated GLP-1 in patients with gastric bypass, one included twins, and, one study included individuals with acquired hypothalamic damage
It works by simultaneously activating three receptors glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors producing significant reductions in body weight and improvements in metabolic markers
Final thoughts: Compounded semaglutide Compounded semaglutide offered relief to those who needed Ozempic and Wegovy for a few years during an active shortage